Joseph Papa’s next office in a pharma industry executive suite is at Emergent BioSolutions, Inc., the Maryland firm manufacturing Narcan, the first OTC naloxone product available in the US after becoming synonymous with opioid overdose emergency treatment.
OTC Naloxone Pioneer Emergent BioSolutions Puts Papa At Helm As It Navigates Strategy Shift
Papa Takes OTC Naloxone Pioneer Emergent BioSolutions Helm As It Navigates Strategy Shift
Like his previous move, Papa joins a pharma firm making a significant organizational shift to cut costs and increase revenues after extended period of higher spending and slowing income.